Tags

Type your tag names separated by a space and hit enter

FDA panel advises easing restrictions on rosiglitazone.
BMJ. 2013 Jun 10; 346:f3769.BMJ

Authors

No affiliation info available

Pub Type(s)

News

Language

eng

PubMed ID

23752055

Citation

Tucker, Miriam E.. "FDA Panel Advises Easing Restrictions On Rosiglitazone." BMJ (Clinical Research Ed.), vol. 346, 2013, pp. f3769.
Tucker ME. FDA panel advises easing restrictions on rosiglitazone. BMJ. 2013;346:f3769.
Tucker, M. E. (2013). FDA panel advises easing restrictions on rosiglitazone. BMJ (Clinical Research Ed.), 346, f3769. https://doi.org/10.1136/bmj.f3769
Tucker ME. FDA Panel Advises Easing Restrictions On Rosiglitazone. BMJ. 2013 Jun 10;346:f3769. PubMed PMID: 23752055.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - FDA panel advises easing restrictions on rosiglitazone. A1 - Tucker,Miriam E, Y1 - 2013/06/10/ PY - 2013/6/12/entrez PY - 2013/6/12/pubmed PY - 2013/8/7/medline SP - f3769 EP - f3769 JF - BMJ (Clinical research ed.) JO - BMJ VL - 346 SN - 1756-1833 UR - https://www.unboundmedicine.com/medline/citation/23752055/FDA_panel_advises_easing_restrictions_on_rosiglitazone_ L2 - http://www.bmj.com/cgi/pmidlookup?view=long&pmid=23752055 DB - PRIME DP - Unbound Medicine ER -